Industries worldwide face mounting pressure to enhance diagnostic accuracy, accelerate inspection processes, and reduce operational costs. This technology aligns perfectly with these trends by offering a software-only upgrade path for existing quantum beam systems. It enables higher resolution imaging for micro-defect detection and early disease diagnosis, crucial for maintaining competitive edge and meeting stringent quality and safety standards across manufacturing, healthcare, and security sectors.
Reduces Capital Expenditure by 90% or More: Achieves high-precision phase imaging through software-only implementation, requiring no hardware modifications to existing quantum beam systems.
Shortens Inspection Time by 20% and Enhances Precision: Eliminates the need for multiple exposures, enabling a 20% reduction in inspection time while simultaneously achieving high-spatial-resolution phase image acquisition with a single shot.
Superior Uniqueness Over Competing Technologies: Secured patentability after comparison with 8 prior art documents, establishing a robust and stable right that offers a clear differentiation factor to replace existing products.
This patent establishes broad and robust protection for a phase image acquisition method and apparatus, specifically covering a weighted processing technique using an approximate phase image. The claims were meticulously refined and successfully defended against examiner objections, demonstrating a strong and stable right that was granted after comparison with 8 prior art documents.
This patent primarily covers software-based image processing. Licensees could develop additional IP in novel quantum beam source or detector hardware, or advanced AI-driven automated defect recognition systems that leverage the high-resolution phase images generated by this technology.
Avoiding hardware investment (average ~$2M (AI est.)) for X-ray CT device upgrades, coupled with a 20% reduction in inspection time (saving ~$20K/year (AI est.) in personnel costs) and improved inspection accuracy reducing defect rates and re-inspections (estimated ~$150K/year (AI est.)), is projected to generate an annual economic impact of over ~$200K (AI est.).
X: Deployment Cost Efficiency
Y: Inspection Accuracy & Speed